Survey on patient preferences for tinnitus treatment options
Tinnitus Patient Preferences Survey
This study is looking to understand what people with chronic tinnitus think about a new brain implant treatment that could help reduce their symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Neurosoft Bioelectronics SA Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06782308 on ClinicalTrials.gov |
What this trial studies
This observational survey aims to gather insights from individuals suffering from chronic tinnitus regarding their preferences for invasive electrical brain stimulation as a treatment option. Participants will provide feedback on their acceptance of a surgically-placed brain implant, the associated risks of the procedure, usability considerations, and their willingness to pay for such a treatment. The data collected will inform Neurosoft Bioelectronics in the development of a minimally invasive brain implant designed to alleviate tinnitus symptoms. The goal is to create a solution that minimizes patient burden while effectively managing tinnitus through a closed-loop feedback system.
Who should consider this trial
Good fit: Ideal candidates for this survey are individuals aged 18 or older who have been diagnosed with chronic, subjective tinnitus lasting three months or longer.
Not a fit: Patients under 18 years of age or healthy volunteers without tinnitus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to the development of a novel treatment that significantly improves the quality of life for individuals suffering from chronic tinnitus.
How similar studies have performed: While this approach is innovative, similar studies focusing on patient preferences for neuromodulation treatments have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Individuals aged 18 or older suffering from subjective tinnitus * Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus Exclusion criteria: * Individuals under 18 years of age * Healthy volunteers without tinnitus
Where this trial is running
New York, New York
- Neurosoft Bielectronics US Inc. — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Nicolas Gninenko, PhD — Neurosoft Bioelectronics
- Study coordinator: Nicolas Gninenko, PhD
- Email: clinical@neurosoft-bio.com
- Phone: 000-000-0000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.